Valuation Update With 7 Day Price Move • May 21
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₩12,830, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total returns to shareholders of 87% over the past three years. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩15,460, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 126% over the past three years. Upcoming Dividend • Mar 24
Upcoming dividend of ₩261 per share Eligible shareholders must have bought the stock before 31 March 2026. Payment date: 24 April 2026. Payout ratio is on the higher end at 96%, however this is supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of South Korean dividend payers (3.7%). Higher than average of industry peers (1.7%). Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩12,820, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total returns to shareholders of 119% over the past three years. Anuncio • Mar 13
Able C&C Co., Ltd., Annual General Meeting, Mar 31, 2026 Able C&C Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 78, namdaemun-ro, jung-gu, seoul South Korea Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to ₩9,560, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 54% over the past three years. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩12,020, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 23x in the Personal Products industry in South Korea. Total returns to shareholders of 98% over the past three years. Anuncio • Feb 11
Able C&C Co., Ltd. (KOSE:A078520) announces an Equity Buyback for KRW 20,000 million worth of its shares. Able C&C Co., Ltd. (KOSE:A078520) announces a share repurchase program. Under the program, the company will repurchase up to KRW 20,000 worth of its shares pursuant to a contract with Shinhan Investment & Securities Co., Ltd. The purpose of the program is to improve shareholder value. The program will expire on August 11, 2026. As of February 10, 2026, the company had 10,50,735 shares in treasury within scope available for dividend and had 3 shares in treasury through other repurchase. Buy Or Sell Opportunity • Feb 10
Now 20% undervalued Over the last 90 days, the stock has risen 15% to ₩11,300. The fair value is estimated to be ₩14,171, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Buy Or Sell Opportunity • Dec 26
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.8% to ₩10,510. The fair value is estimated to be ₩13,404, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to ₩12,980, the stock trades at a trailing P/E ratio of 30x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total returns to shareholders of 218% over the past three years. Buy Or Sell Opportunity • Nov 21
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 13% to ₩9,800. The fair value is estimated to be ₩13,310, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Nov 20
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩10,810, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 21x in the Personal Products industry in South Korea. Total returns to shareholders of 175% over the past three years. Reported Earnings • Nov 16
Third quarter 2025 earnings released: ₩13.00 loss per share (vs ₩151 profit in 3Q 2024) Third quarter 2025 results: ₩13.00 loss per share (down from ₩151 profit in 3Q 2024). Revenue: ₩59.5b (down 5.5% from 3Q 2024). Net loss: ₩325.7m (down 108% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩12,020, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 22x in the Personal Products industry in South Korea. Total returns to shareholders of 126% over the past three years. Valuation Update With 7 Day Price Move • Aug 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩13,270, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 188% over the past three years. Reported Earnings • Aug 19
Second quarter 2025 earnings released: EPS: ₩152 (vs ₩139 in 2Q 2024) Second quarter 2025 results: EPS: ₩152 (up from ₩139 in 2Q 2024). Revenue: ₩67.7b (up 3.1% from 2Q 2024). Net income: ₩3.94b (up 9.1% from 2Q 2024). Profit margin: 5.8% (up from 5.5% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 08
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩11,300, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 165% over the past three years. Buy Or Sell Opportunity • Jul 22
Now 23% undervalued Over the last 90 days, the stock has risen 31% to ₩8,920. The fair value is estimated to be ₩11,548, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.9% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩9,290, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 124% over the past three years. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩6,640, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 10% over the past three years. Upcoming Dividend • Mar 21
Upcoming dividend of ₩204 per share Eligible shareholders must have bought the stock before 28 March 2025. Payment date: 25 April 2025. Payout ratio is on the higher end at 79%, and the cash payout ratio is above 100%. Trailing yield: 3.0%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (1.1%). Anuncio • Mar 18
Able C&C Co., Ltd., Annual General Meeting, Mar 31, 2025 Able C&C Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 78, namdaemun-ro, jung-gu, seoul South Korea New Risk • Nov 20
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 311% Cash payout ratio: 434% High level of non-cash earnings (23% accrual ratio). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to ₩6,890, the stock trades at a trailing P/E ratio of 27.7x. Average trailing P/E is 24x in the Personal Products industry in South Korea. Total loss to shareholders of 10% over the past three years. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩10,780, the stock trades at a trailing P/E ratio of 43.4x. Average trailing P/E is 26x in the Personal Products industry in South Korea. Total returns to shareholders of 39% over the past three years. Valuation Update With 7 Day Price Move • May 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩8,340, the stock trades at a trailing P/E ratio of 35.4x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Total returns to shareholders of 18% over the past three years. New Risk • Apr 27
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 6x earnings per share. Cash payout ratio: 169% Minor Risk Shareholders have been diluted in the past year (4.1% increase in shares outstanding). Upcoming Dividend • Mar 22
Upcoming dividend of ₩157 per share Eligible shareholders must have bought the stock before 29 March 2024. Payment date: 29 April 2024. Trailing yield: 22%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.2%). Reported Earnings • Nov 19
Third quarter 2023 earnings released: EPS: ₩45.00 (vs ₩85.00 in 3Q 2022) Third quarter 2023 results: EPS: ₩45.00 (down from ₩85.00 in 3Q 2022). Revenue: ₩65.3b (up 11% from 3Q 2022). Net income: ₩1.18b (down 45% from 3Q 2022). Profit margin: 1.8% (down from 3.7% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩8,450, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Total returns to shareholders of 26% over the past three years. Upcoming Dividend • Sep 20
Upcoming dividend of ₩1,270 per share Eligible shareholders must have bought the stock before 27 September 2023. Payment date: 18 October 2023. The company last paid an ordinary dividend in March 2014. The average dividend yield among industry peers is 0.8%. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩9,200, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 28x in the Personal Products industry in South Korea. Total returns to shareholders of 20% over the past three years. New Risk • Aug 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Buying Opportunity • Aug 11
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 8.7%. The fair value is estimated to be ₩11,306, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Aug 07
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩7,270, the stock trades at a trailing P/E ratio of 36.8x. Average trailing P/E is 27x in the Personal Products industry in South Korea. Total loss to shareholders of 9.8% over the past three years. Buying Opportunity • Jun 29
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be ₩9,420, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Jun 13
Now 21% undervalued Over the last 90 days, the stock is up 6.1%. The fair value is estimated to be ₩9,448, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Apr 19
Full year 2021 earnings released: ₩1,666 loss per share (vs ₩3,387 loss in FY 2020) Full year 2021 results: ₩1,666 loss per share (up from ₩3,387 loss in FY 2020). Revenue: ₩262.9b (down 14% from FY 2020). Net loss: ₩43.3b (loss narrowed 51% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance. Anuncio • Mar 05
Able C&C Co., Ltd., Annual General Meeting, Mar 31, 2021 Able C&C Co., Ltd., Annual General Meeting, Mar 31, 2021, at 10:00 Korea Standard Time. Location: 12 Seocho-daero 38-gil (Seocho-dong, Majestar City Tower One), Seocho-gu Seoul South Korea Is New 90 Day High Low • Jan 11
New 90-day low: ₩7,160 The company is down 8.0% from its price of ₩7,750 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. Reported Earnings • Nov 22
Third quarter 2020 earnings released: ₩516 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: ₩67.0b (down 29% from 3Q 2019). Net loss: ₩13.4b (loss widened 131% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 107% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Nov 20
New 90-day high: ₩8,150 The company is up 2.0% from its price of ₩7,960 on 21 August 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is down 1.0% over the same period. Is New 90 Day High Low • Sep 22
New 90-day low: ₩7,210 The company is down 16% from its price of ₩8,630 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 11% over the same period.